世界の造血幹細胞移植(HSCT)市場2023年~2027年

【英語タイトル】Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2023-2027

Technavioが出版した調査資料(IRTNTR41656-23)・商品コード:IRTNTR41656-23
・発行会社(調査会社):Technavio
・発行日:2023年1月2日
・ページ数:159
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の市場調査によると、世界の造血幹細胞移植(HSCT)市場は2022年から2027年の間に2,383.61百万ドルへ成長し、2022年から2027年の間にCAGR 6.5%拡大する見通しです。当調査資料では、造血幹細胞移植(HSCT)の世界市場を広く調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別(骨髄移植、末梢血幹細胞移植、臍帯血移植)分析、種類別(自家造血幹細胞移植(HSCT)、同種異系造血幹細胞移植(HSCT))分析、顧客状況、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、イギリス、ドイツ、カナダ、中国)分析、成長要因・課題・動向、企業状況、企業分析など、以下の構成でお届けします。また、当資料には、Athersys Inc.、Beike Biotechnology Co. Ltd.、bluebird bio Inc.、Cellular Biomedicine Group Inc.、FUJIFILM Corp.、Gamida Cell Ltd.、Lineage Cell Therapeutics Inc.などの企業情報が含まれております。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界の造血幹細胞移植(HSCT)市場規模:用途別
- 骨髄移植における市場規模
- 末梢血幹細胞移植における市場規模
- 臍帯血移植における市場規模
・世界の造血幹細胞移植(HSCT)市場規模:種類別
- 自家造血幹細胞移植(HSCT)の市場規模
- 同種異系造血幹細胞移植(HSCT)の市場規模
・顧客状況
・世界の造血幹細胞移植(HSCT)市場規模:地域別
- 北米の造血幹細胞移植(HSCT)市場
- ヨーロッパの造血幹細胞移植(HSCT)市場
- アジアの造血幹細胞移植(HSCT)市場
- その他地域の造血幹細胞移植(HSCT)市場
- アメリカの造血幹細胞移植(HSCT)市場
- イギリスの造血幹細胞移植(HSCT)市場
- ドイツの造血幹細胞移植(HSCT)市場
- カナダの造血幹細胞移植(HSCT)市場
- 中国の造血幹細胞移植(HSCT)市場
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターの分析や、複数のソースからのデータを調査、統合、および総括することにより、市場の詳細な全体像を提供します。主要産業のインフルエンサーを特定することで、市場の様々な側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査資料は、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

造血幹細胞移植(HSCT)の世界市場 2023-2027

Technavio社は、造血幹細胞移植(HSCT)市場をモニターしており、2022年から2027年にかけて2,383.61百万ドルの成長が予測され、予測期間中のCAGRは6.5%で加速すると予測しています。当レポートでは、造血幹細胞移植(HSCT)市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場を牽引するのは、技術的に高度な機器の入手可能性、再生医療分野への投資の増加、造血幹細胞移植の増加です。

Technavio社の造血幹細胞移植(HSCT)市場は以下のように分類されます:

・用途別:
- 骨髄移植
- 末梢血幹細胞移植
- 臍帯血移植

・タイプ別:
- 自家造血幹細胞移植
- 同種造血幹細胞移植

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、個別化医療に対する需要の高まりが、今後数年間の造血幹細胞移植(HSCT)市場の成長を牽引する主な要因の一つであると分析しています。また、罹患率や死亡率の低下、臍帯血バンクの出現は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、統合、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、造血幹細胞移植(HSCT)市場について、以下の分野をカバーしています:
- 造血幹細胞移植(HSCT)市場のサイジング
- 造血幹細胞移植(HSCT)市場予測
- 造血幹細胞移植(HSCT)市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Athersys Inc., Beike Biotechnology Co. Ltd., bluebird bio Inc., Cellular Biomedicine Group Inc., FUJIFILM Corp., Gamida Cell Ltd., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Mesoblast Ltd., Pluristem Therapeutics Inc., Sanofi SA, Sartorius CellGenix GmbH, Taiga Biotechnologies Inc., Takeda Pharmaceutical Co. Ltd., Talaris Therapeutics Inc., ThermoGenesis Holdings Inc., and AllCells Corpなどの企業情報が含まれています。また、造血幹細胞移植(HSCT)市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global hematopoietic stem cells transplantation (HSCT) market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global hematopoietic stem cells transplantation (HSCT) market 2017 – 2021 ($ million)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Bone marrow transplant – Market size and forecast 2022-2027
o Exhibit 34: Chart on Bone marrow transplant – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Bone marrow transplant – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Bone marrow transplant – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Bone marrow transplant – Year-over-year growth 2022-2027 (%)
o 6.4 Peripheral blood stem cell transplant – Market size and forecast 2022-2027
o Exhibit 38: Chart on Peripheral blood stem cell transplant – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Peripheral blood stem cell transplant – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Peripheral blood stem cell transplant – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Peripheral blood stem cell transplant – Year-over-year growth 2022-2027 (%)
o 6.5 Cord blood transplant – Market size and forecast 2022-2027
o Exhibit 42: Chart on Cord blood transplant – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Cord blood transplant – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Cord blood transplant – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Cord blood transplant – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Application
o Exhibit 46: Market opportunity by Application ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 47: Chart on Type – Market share 2022-2027 (%)
o Exhibit 48: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 49: Chart on Comparison by Type
o Exhibit 50: Data Table on Comparison by Type
o 7.3 Autologous HSCT – Market size and forecast 2022-2027
o Exhibit 51: Chart on Autologous HSCT – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Autologous HSCT – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Autologous HSCT – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Autologous HSCT – Year-over-year growth 2022-2027 (%)
o 7.4 Allogeneic HSCT – Market size and forecast 2022-2027
o Exhibit 55: Chart on Allogeneic HSCT – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Allogeneic HSCT – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Allogeneic HSCT – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Allogeneic HSCT – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 59: Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 85: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 93: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 AllCells Corp.
o Exhibit 108: AllCells Corp. – Overview
o Exhibit 109: AllCells Corp. – Product / Service
o Exhibit 110: AllCells Corp. – Key offerings
o 12.4 Athersys Inc.
o Exhibit 111: Athersys Inc. – Overview
o Exhibit 112: Athersys Inc. – Product / Service
o Exhibit 113: Athersys Inc. – Key offerings
o 12.5 Beike Biotechnology Co. Ltd.
o Exhibit 114: Beike Biotechnology Co. Ltd. – Overview
o Exhibit 115: Beike Biotechnology Co. Ltd. – Product / Service
o Exhibit 116: Beike Biotechnology Co. Ltd. – Key offerings
o 12.6 bluebird bio Inc.
o Exhibit 117: bluebird bio Inc. – Overview
o Exhibit 118: bluebird bio Inc. – Product / Service
o Exhibit 119: bluebird bio Inc. – Key offerings
o 12.7 Cellular Biomedicine Group Inc.
o Exhibit 120: Cellular Biomedicine Group Inc. – Overview
o Exhibit 121: Cellular Biomedicine Group Inc. – Product / Service
o Exhibit 122: Cellular Biomedicine Group Inc. – Key offerings
o 12.8 FUJIFILM Corp.
o Exhibit 123: FUJIFILM Corp. – Overview
o Exhibit 124: FUJIFILM Corp. – Business segments
o Exhibit 125: FUJIFILM Corp. – Key news
o Exhibit 126: FUJIFILM Corp. – Key offerings
o Exhibit 127: FUJIFILM Corp. – Segment focus
o 12.9 Gamida Cell Ltd.
o Exhibit 128: Gamida Cell Ltd. – Overview
o Exhibit 129: Gamida Cell Ltd. – Product / Service
o Exhibit 130: Gamida Cell Ltd. – Key offerings
o 12.10 Lineage Cell Therapeutics Inc.
o Exhibit 131: Lineage Cell Therapeutics Inc. – Overview
o Exhibit 132: Lineage Cell Therapeutics Inc. – Product / Service
o Exhibit 133: Lineage Cell Therapeutics Inc. – Key offerings
o 12.11 Lonza Group Ltd.
o Exhibit 134: Lonza Group Ltd. – Overview
o Exhibit 135: Lonza Group Ltd. – Business segments
o Exhibit 136: Lonza Group Ltd. – Key news
o Exhibit 137: Lonza Group Ltd. – Key offerings
o Exhibit 138: Lonza Group Ltd. – Segment focus
o 12.12 MEDIPOST Co. Ltd.
o Exhibit 139: MEDIPOST Co. Ltd. – Overview
o Exhibit 140: MEDIPOST Co. Ltd. – Product / Service
o Exhibit 141: MEDIPOST Co. Ltd. – Key offerings
o 12.13 Merck and Co. Inc.
o Exhibit 142: Merck and Co. Inc. – Overview
o Exhibit 143: Merck and Co. Inc. – Business segments
o Exhibit 144: Merck and Co. Inc. – Key news
o Exhibit 145: Merck and Co. Inc. – Key offerings
o Exhibit 146: Merck and Co. Inc. – Segment focus
o 12.14 Mesoblast Ltd.
o Exhibit 147: Mesoblast Ltd. – Overview
o Exhibit 148: Mesoblast Ltd. – Product / Service
o Exhibit 149: Mesoblast Ltd. – Key offerings
o 12.15 Sanofi SA
o Exhibit 150: Sanofi SA – Overview
o Exhibit 151: Sanofi SA – Business segments
o Exhibit 152: Sanofi SA – Key news
o Exhibit 153: Sanofi SA – Key offerings
o Exhibit 154: Sanofi SA – Segment focus
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 155: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 156: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 157: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 158: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 12.17 ThermoGenesis Holdings Inc.
o Exhibit 159: ThermoGenesis Holdings Inc. – Overview
o Exhibit 160: ThermoGenesis Holdings Inc. – Product / Service
o Exhibit 161: ThermoGenesis Holdings Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 162: Inclusions checklist
o Exhibit 163: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 164: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 165: Research methodology
o Exhibit 166: Validation techniques employed for market sizing
o Exhibit 167: Information sources
o 13.5 List of abbreviations
o Exhibit 168: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global hematopoietic stem cells transplantation (HSCT) market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Bone marrow transplant – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Bone marrow transplant – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Bone marrow transplant – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Bone marrow transplant – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Peripheral blood stem cell transplant – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Peripheral blood stem cell transplant – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Peripheral blood stem cell transplant – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Peripheral blood stem cell transplant – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Cord blood transplant – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Cord blood transplant – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Cord blood transplant – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Cord blood transplant – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Application ($ million)
Exhibits47: Chart on Type – Market share 2022-2027 (%)
Exhibits48: Data Table on Type – Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Type
Exhibits50: Data Table on Comparison by Type
Exhibits51: Chart on Autologous HSCT – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Autologous HSCT – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Autologous HSCT – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Autologous HSCT – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Allogeneic HSCT – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Allogeneic HSCT – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Allogeneic HSCT – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Allogeneic HSCT – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Type ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: AllCells Corp. – Overview
Exhibits109: AllCells Corp. – Product / Service
Exhibits110: AllCells Corp. – Key offerings
Exhibits111: Athersys Inc. – Overview
Exhibits112: Athersys Inc. – Product / Service
Exhibits113: Athersys Inc. – Key offerings
Exhibits114: Beike Biotechnology Co. Ltd. – Overview
Exhibits115: Beike Biotechnology Co. Ltd. – Product / Service
Exhibits116: Beike Biotechnology Co. Ltd. – Key offerings
Exhibits117: bluebird bio Inc. – Overview
Exhibits118: bluebird bio Inc. – Product / Service
Exhibits119: bluebird bio Inc. – Key offerings
Exhibits120: Cellular Biomedicine Group Inc. – Overview
Exhibits121: Cellular Biomedicine Group Inc. – Product / Service
Exhibits122: Cellular Biomedicine Group Inc. – Key offerings
Exhibits123: FUJIFILM Corp. – Overview
Exhibits124: FUJIFILM Corp. – Business segments
Exhibits125: FUJIFILM Corp. – Key news
Exhibits126: FUJIFILM Corp. – Key offerings
Exhibits127: FUJIFILM Corp. – Segment focus
Exhibits128: Gamida Cell Ltd. – Overview
Exhibits129: Gamida Cell Ltd. – Product / Service
Exhibits130: Gamida Cell Ltd. – Key offerings
Exhibits131: Lineage Cell Therapeutics Inc. – Overview
Exhibits132: Lineage Cell Therapeutics Inc. – Product / Service
Exhibits133: Lineage Cell Therapeutics Inc. – Key offerings
Exhibits134: Lonza Group Ltd. – Overview
Exhibits135: Lonza Group Ltd. – Business segments
Exhibits136: Lonza Group Ltd. – Key news
Exhibits137: Lonza Group Ltd. – Key offerings
Exhibits138: Lonza Group Ltd. – Segment focus
Exhibits139: MEDIPOST Co. Ltd. – Overview
Exhibits140: MEDIPOST Co. Ltd. – Product / Service
Exhibits141: MEDIPOST Co. Ltd. – Key offerings
Exhibits142: Merck and Co. Inc. – Overview
Exhibits143: Merck and Co. Inc. – Business segments
Exhibits144: Merck and Co. Inc. – Key news
Exhibits145: Merck and Co. Inc. – Key offerings
Exhibits146: Merck and Co. Inc. – Segment focus
Exhibits147: Mesoblast Ltd. – Overview
Exhibits148: Mesoblast Ltd. – Product / Service
Exhibits149: Mesoblast Ltd. – Key offerings
Exhibits150: Sanofi SA – Overview
Exhibits151: Sanofi SA – Business segments
Exhibits152: Sanofi SA – Key news
Exhibits153: Sanofi SA – Key offerings
Exhibits154: Sanofi SA – Segment focus
Exhibits155: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits156: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits157: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits158: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits159: ThermoGenesis Holdings Inc. – Overview
Exhibits160: ThermoGenesis Holdings Inc. – Product / Service
Exhibits161: ThermoGenesis Holdings Inc. – Key offerings
Exhibits162: Inclusions checklist
Exhibits163: Exclusions checklist
Exhibits164: Currency conversion rates for US$
Exhibits165: Research methodology
Exhibits166: Validation techniques employed for market sizing
Exhibits167: Information sources
Exhibits168: List of abbreviations



★調査レポート[世界の造血幹細胞移植(HSCT)市場2023年~2027年] (コード:IRTNTR41656-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の造血幹細胞移植(HSCT)市場2023年~2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆